Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Matteo Ziacchi, Alberto Spadotto, Stefano Ghio, Marta Pellegrino, Luciano Potena, Daniele Masarone, Marco Merlo, Davide Stolfo, Maria Michela Caracciolo, Corinna Inserra, Fabrizio Ammirati, Michele Ciccarelli, Furio Colivicchi, Stefano Bianchi, Giuseppe Patti, Fabrizio Oliva, Giuseppe Arcidiacono, Roberto Rordorf, Daniela Pini, Giuseppe Pacileo, Antonio D’Onofrio, Giovanni Battista Forleo, Matteo Mariani, Francesco Adamo, Alessandro Alonzo, Matteo Ruzzolini, Chiara Ghiglieno, Manlio Cipriani, Giorgio Firetto, Nadia Aspromonte, Francesco Clemenza, Gaetano Maria De Ferrari, Michele Senni, Maria Grazia Bongiorni, Claudio Tondo, Massimo Grimaldi, Francesco Giallauria, Francesco Rametta, Procolo Marchese, Mauro Biffi & Gianfranco Sinagra. (2023) Bridging the gap in the symptomatic heart failure patient journey: insights from the Italian scenario. Expert Review of Medical Devices 20:11, pages 951-961.
Read now
Read now
Daniele Masarone, Ishu Rao & Giuseppe Pacileo. (2023) HOPE for a better selection of patients for cardiac contractility modulation. Expert Review of Medical Devices 20:7, pages 525-528.
Read now
Read now
Articles from other publishers (14)
Ying Wu, Meiyan Song, Meifang Wu & Liming Lin. (2023) Advances in device‐based treatment of heart failure with preserved ejection fraction: evidence from clinical trials. ESC Heart Failure.
Crossref
Crossref
Zihan Li, Qiming Liu, Shenghua Zhou & Yichao Xiao. (2023) Enhancing myocardial function with cardiac contractility modulation: potential and challenges. ESC Heart Failure.
Crossref
Crossref
Daniele Masarone, Michelle M. Kittleson, Antonio D’Onofrio, Luigi Falco, Isabella Fumarolo, Massimo Massetti, Filippo Crea, Nadia Aspromonte & Giuseppe Pacileo. (2023) Basic Science of Cardiac Contractility Modulation Therapy: Molecular and Electrophysiological Mechanisms. Heart Rhythm.
Crossref
Crossref
Mauro Riccardi, Antonio M. Sammartino, Marianna Adamo, Riccardo M. Inciardi, Carlo M. Lombardi, Nicola R. Pugliese, Daniela Tomasoni, Enrico Vizzardi, Marco Metra, Andrew J. S. Coats & Matteo Pagnesi. (2023) Cardiac contractility modulation: an effective treatment strategy for heart failure beyond reduced left ventricular ejection fraction?. Heart Failure Reviews 28:5, pages 1141-1149.
Crossref
Crossref
Daniele Masarone, Michelle M. Kittleson, Stefano De Vivo, Antonio D’Onofrio, Ishu Rao, Ernesto Ammendola, Vittoria Errigo, Maria L. Martucci, Gerardo Nigro & Giuseppe Pacileo. (2022) Effects of Cardiac Contractility Modulation Electrodes on Tricuspid Regurgitation in Patients with Heart Failure with Reduced Ejection Fraction: A Pilot Study. Journal of Clinical Medicine 11:24, pages 7442.
Crossref
Crossref
KHAWAJA M. TALHA, STEFAN D. ANKER, DANIEL BURKHOFF, GERASIMOS FILIPPATOS, CAROLYN S.P. LAM, GREGG W. STONE, OUSSAMA WAZNI & JAVED BUTLER. (2022) Role of Cardiac Contractility Modulation in Heart Failure With a Higher Ejection Fraction. Journal of Cardiac Failure 28:12, pages 1717-1726.
Crossref
Crossref
Soraya Samii & Gerald V. Naccarelli. (2022) Cardiac Contractility Modulation Therapy: Should We Be Aiming Higher for Patients With Moderately Severe Heart Failure?. Texas Heart Institute Journal 49:6.
Crossref
Crossref
Karine Vartanian, Miguel Franco, Nathalie Busse, Sofiia Bidzhoian, Tesnim Hamdan & Ernst R. von Schwarz. (2022) Improved Physical Function After Cardiac Contractility Modulation Therapy in 10 Patients With Chronic Heart Failure. Texas Heart Institute Journal 49:6.
Crossref
Crossref
Christian Fastner, Goekhan Yuecel, Svetlana Hetjens, Boris Rudic, Gereon Schmiel, Matthias Toepel, Volker Liebe, Mathieu Kruska, Martin Borggrefe, Daniel Burkhoff, Ibrahim Akin, Daniel Duerschmied & Juergen Kuschyk. (2022) Should HFrEF patients with NYHA class II expect benefit from CCM therapy? Results from the MAINTAINED observational study. Clinical Research in Cardiology 111:11, pages 1286-1294.
Crossref
Crossref
Mary Ann Leavitt. (2022) CE: Guideline-Directed Cardiac Devices for Patients with Heart Failure. AJN, American Journal of Nursing 122:6, pages 24-31.
Crossref
Crossref
Khawaja M. Talha & Javed Butler. (2022) Breakthroughs in the treatment of heart failure with mildly reduced and preserved ejection fraction. Clinical Cardiology 45:S1.
Crossref
Crossref
Valeria Visco, Cristina Esposito, Michele Manzo, Antonio Fiorentino, Gennaro Galasso, Carmine Vecchione & Michele Ciccarelli. (2022) A Multistep Approach to Deal With Advanced Heart Failure: A Case Report on the Positive Effect of Cardiac Contractility Modulation Therapy on Pulmonary Pressure Measured by CardioMEMS. Frontiers in Cardiovascular Medicine 9.
Crossref
Crossref
Feifei Zhang, Litian Liu, Yuetao Xie, Jiaqi Wang, Xuefeng Chen, Shihang Zheng, Yingxiao Li & Yi Dang. (2022) Cardiac contractility modulation ameliorates myocardial metabolic remodeling in a rabbit model of chronic heart failure through activation of AMPK and PPAR-α pathway. Open Medicine 17:1, pages 365-374.
Crossref
Crossref
Adebayo Oluwafemi Adekunle, Gabriel Komla Adzika, Richard Mprah, Marie Louise Ndzie Noah, Joseph Adu-Amankwaah, Ruqayya Rizvi, Nazma Akhter & Hong Sun. (2021) Predominance of Heart Failure With Preserved Ejection Fraction in Postmenopausal Women: Intra- and Extra-Cardiomyocyte Maladaptive Alterations Scaffolded by Estrogen Deficiency. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref